Senior Editor, Diagnostic Imaging
Canon Medical Launches New CT and X-Ray Modalities at ECR 2023March 2nd 2023
The new launches include the 80/160-slice computed tomography (CT) scanner Aquilion Serve, which allows simultaneous previews of axial, lateral and AP views, and Celex, a multipurpose X-ray system that offers automated and customizable features to help maximize workflow efficiencies.
Could a New PSMA PET Agent Improve Detection of Distant Metastatic Lesions in Patients with Prostate Cancer?March 2nd 2023
In a video interview from the recent American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium, Brian Chapin, MD, discussed emerging research that demonstrated the ability of the positron emission tomography (PET) agent 18F-rhPSMA-7.3 to diagnose distant M1 lesions prior to surgery for patients with intermediate to high-risk prostate cancer.
New Study Shows Benefits of Prostate Artery Embolization for Men with an Enlarged ProstateMarch 1st 2023
Prostate artery embolization led to a 32 percent reduction of the prostate gland and a 42 percent decrease in prostate-specific antigen (PSA) values one year after the procedure, according to new research presented recently at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Phoenix.
Cancer Screenings and COVID-19: What a New Study ShowsFebruary 27th 2023
New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.
AI/CT Combination for Assessing Pulmonary Embolism Severity Gets FDA NodFebruary 23rd 2023
Facilitating expedited assessment of pulmonary embolism severity, the emerging artificial intelligence (AI) tool Rapid RV/LV reportedly calculates the right ventricle/left ventricle (RV/LV) ratio within minutes of a computed tomography pulmonary angiogram (CTPA).
Can a New AI Tool Improve Detection of Incidental Pulmonary Embolism on CT?February 22nd 2023
Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Is Follow-Up Pelvic CT Coverage Necessary for Patients Treated for Hepatocellular Carcinoma?February 22nd 2023
Noting that pelvic coverage can increase radiation dosing for liver computed tomography (CT) by 29 to 39 percent, researchers found low three-year cumulative rates of incidental pelvic tumors and isolated pelvic metastasis in follow-up liver CT imaging of over 1,100 people treated for hepatocellular carcinoma.
Overcoming Burnout in RadiologyFebruary 21st 2023
In a recent video interview, radiologist Jonathon Lee, MD, shared insights from his experience on the insidious nature of burnout, emphasized the link between work-life balance and productivity, and discussed a recent partnership between the teleradiology service provider vRad and the behavioral health consultancy VITAL WorkLife to help promote well-being for vRad teleradiologists.
How Accurate is the CT Severity Score for Predicting COVID-19 Severity?February 17th 2023
The computed tomography severity score (CTSS) has sensitivity rates of 85 percent for predicting the severity of COVID-19 and 77 percent for predicting COVID-19 related mortality, according to a newly published meta-analysis.
Recurrent Prostate Cancer and Low PSA Levels: Can an Emerging PSMA PET Agent Have an Impact?February 16th 2023
Use of the prostate-specific membrane antigen (PSMA) positron emission tomography (PET) agent piflufolastat F 18 led to treatment plan changes in nearly 40 percent of men with recurrent prostate cancer and low prostate-specific antigen (PSA) levels, according to new research presented recently at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium in San Francisco.
Could Photon Counting CT Supplant MRI for Imaging Assessment of Hepatic Steatosis?February 16th 2023
Preliminary research suggests no significant differences between photon-counting computed tomography (CT) and magnetic resonance imaging (MRI) in the quantification of liver fat fraction in obese patients.
Can an Emerging Radiomics Model Improve CT Angiography Assessment of Heart Attack Risk?February 14th 2023
Derived from coronary computed tomography angiography (CCTA) images, a radiomics model demonstrated a 75 percent or greater area under the curve (AUC) in multiple test sets for identifying vulnerable plaque.
Emerging Trends with AI in Radiology in 2023February 13th 2023
In a recent video interview, Sonia Gupta, MD discussed a number of ongoing developments with artificial intelligence (AI) in radiology, ranging from market consolidation of AI vendors to maximizing automation and efficiency with patient triage, reporting and follow-up of incidental findings.
Can Pre-Op Ultrafast MRI Predict Upgrade of DCIS Lesions to Invasive Breast Cancer?February 9th 2023
In a new study that may have implications for breast cancer surgery, researchers found that shorter time to enhancement (TTE) on preoperative ultrafast magnetic resonance imaging (MRI) was significantly associated with escalation of ductal carcinoma in situ (DCIS) to invasive breast cancer.
Study: AI More Than Doubles the Sensitivity Rate for Lung-RADS Category 4 Nodules on Chest X-RaysFebruary 7th 2023
In newly published research, researchers found that an artificial intelligence (AI) computer-aided detection (CAD) system was more than twice as likely as non-AI assessment to diagnose actionable lung nodules on chest X-rays.
Interval Breast Cancer: What a New Mammography Study RevealsFebruary 6th 2023
In a new study of 1,232 women diagnosed with breast cancer within a year of a screening mammography exam, researchers found that interval breast cancer was 17 percent more likely in women with dense or extremely dense breasts, and over three times more likely to involve stage 2 or higher primary tumors in comparison to screening-detected breast cancer.
Can MRI Surveillance Have an Impact in Detecting Recurrence of Soft Tissue Sarcomas?February 3rd 2023
While acknowledging a moderate to high risk of bias in the retrospective studies reviewed for a recent meta-analysis, researchers found the current evidence supports the use of high-intensity magnetic resonance imaging (MRI) surveillance for detection of soft tissue sarcoma recurrence.
New MRI Study Examines Impact of Disparities with Childhood Adversity Exposure on Brain DevelopmentFebruary 2nd 2023
In a study of over 9,000 children that examined structural magnetic resonance imaging (MRI) data as well as parent and child self-reporting of adversity-related measures, researchers found that greater exposure to adversities for Black children was linked to lower gray matter volume in the amygdala and multiple subregions of the prefrontal cortex in comparison to White children.
Clarius Mobile Health Gets FDA Nod for AI Ultrasound Musculoskeletal Imaging ModelFebruary 1st 2023
In what is reportedly the first Food and Drug Administration (FDA) 510(k) clearance for the use of artificial intelligence (AI) for musculoskeletal ultrasound, the model provides automated measurements of tendons in the knee, ankle, and foot.
Can Deep Learning Enhance Pulmonary Nodule Detection on Chest X-Rays?February 1st 2023
In an external validation data set for a deep learning bone-suppressed (DLBS) model, researchers found that adjunctive use of the DLBS model led to a nearly 15 percent increase in sensitivity for detecting pulmonary nodules on chest X-rays in comparison to radiologist assessment.
New Meta-Analysis Says MRI is Best Supplemental Imaging for Dense BreastsJanuary 31st 2023
In a review of 22 studies and data from over 132,000 women with dense breasts and negative mammography exams, researchers found that magnetic resonance imaging (MRI) was superior to digital breast tomosynthesis, handheld ultrasound and automated whole breast ultrasound for the detection of breast cancer.